Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia.
Feb 21, 2013
0
0